Based on our study, therapeutic interventions leading to the maintenance of cancer cell growth arrest can be envisioned, such as inhibition of glycolysis by 2-DG and its analogues, which are currently being considered as anti-cancer drugs (47), or YAP inhibitors, from which several are already in clinical trials (48). Here, YAP1 is linked to cancer.